Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
27801
27802
27803
27804
27805
27806
27807
27808
27809
27810
27811
27812
27813
27814
27815
27816
27817
27818
27819
27820
27821
27822
27823
27824
27825
27826
27827
27828
27829
27830
27831
27832
27833
27834
27835
27836
27837
27838
27839
27840
27841
27842
27843
27844
27845
27846
27847
27848
27849
27850
27851
27852
27853
27854
27855
27856
27857
27858
27859
27860
27861
27862
27863
27864
27865
27866
27867
27868
27869
27870
27871
27872
27873
27874
27875
27876
27877
27878
27879
27880
27881
27882
27883
27884
27885
27886
27887
27888
27889
27890
27891
27892
27893
27894
27895
27896
27897
27898
27899
27900
27901
27902
27903
27904
27905
27906
27907
27908
27909
27910
27911
27912
27913
27914
27915
27916
27917
27918
27919
27920
27921
27922
27923
27924
27925
27926
27927
27928
27929
27930
27931
27932
27933
27934
27935
27936
27937
27938
27939
27940
27941
27942
27943
27944
27945
27946
27947
27948
27949
27950
27951
27952
27953
27954
27955
27956
27957
27958
27959
27960
27961
27962
27963
27964
27965
27966
27967
27968
27969
27970
27971
27972
27973
27974
27975
27976
27977
27978
27979
27980
27981
27982
27983
27984
27985
27986
27987
27988
27989
27990
27991
27992
27993
27994
27995
27996
27997
27998
27999
28000
| UnnamedSample_HQ_transcript/11598|m.4358 | UnnamedSample_HQ_transcript/11598 | Coverage 0.967 too low. | e849782805d26bf01ddae2eb692ad41b | 735 | Pfam | PF17862 | AAA+ lid domain | 418 | 454 | 1.1E-9 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/11598|m.4358 | UnnamedSample_HQ_transcript/11598 | Coverage 0.967 too low. | e849782805d26bf01ddae2eb692ad41b | 735 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 251 | 391 | 8.6E-40 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/11598|m.4358 | UnnamedSample_HQ_transcript/11598 | Coverage 0.967 too low. | e849782805d26bf01ddae2eb692ad41b | 735 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 534 | 662 | 6.1E-12 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/34907|m.10695 | UnnamedSample_HQ_transcript/34907 | Coverage 0.619 too low. | e849782805d26bf01ddae2eb692ad41b | 735 | Pfam | PF02359 | Cell division protein 48 (CDC48), N-terminal domain | 2 | 83 | 8.3E-11 | T | 22-09-2020 | IPR003338 | CDC48, N-terminal subdomain |
| UnnamedSample_HQ_transcript/34907|m.10695 | UnnamedSample_HQ_transcript/34907 | Coverage 0.619 too low. | e849782805d26bf01ddae2eb692ad41b | 735 | Pfam | PF02933 | Cell division protein 48 (CDC48), domain 2 | 107 | 157 | 5.4E-5 | T | 22-09-2020 | IPR004201 | CDC48, domain 2 |
| UnnamedSample_HQ_transcript/34907|m.10695 | UnnamedSample_HQ_transcript/34907 | Coverage 0.619 too low. | e849782805d26bf01ddae2eb692ad41b | 735 | Pfam | PF17862 | AAA+ lid domain | 418 | 454 | 1.1E-9 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/34907|m.10695 | UnnamedSample_HQ_transcript/34907 | Coverage 0.619 too low. | e849782805d26bf01ddae2eb692ad41b | 735 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 251 | 391 | 8.6E-40 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/34907|m.10695 | UnnamedSample_HQ_transcript/34907 | Coverage 0.619 too low. | e849782805d26bf01ddae2eb692ad41b | 735 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 534 | 662 | 6.1E-12 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/11780|m.4421 | UnnamedSample_HQ_transcript/11780 | Coverage 0.260 too low. | 536526fd6223c60d2619846abc9b3b67 | 540 | Pfam | PF00595 | PDZ domain | 461 | 539 | 4.3E-11 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/11780|m.4421 | UnnamedSample_HQ_transcript/11780 | Coverage 0.260 too low. | 536526fd6223c60d2619846abc9b3b67 | 540 | Pfam | PF00595 | PDZ domain | 257 | 334 | 2.1E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/11780|m.4421 | UnnamedSample_HQ_transcript/11780 | Coverage 0.260 too low. | 536526fd6223c60d2619846abc9b3b67 | 540 | Pfam | PF00595 | PDZ domain | 358 | 433 | 3.3E-17 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/11780|m.4421 | UnnamedSample_HQ_transcript/11780 | Coverage 0.260 too low. | 536526fd6223c60d2619846abc9b3b67 | 540 | Pfam | PF00595 | PDZ domain | 32 | 105 | 5.8E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/59497|m.15946 | UnnamedSample_HQ_transcript/59497 | Coverage 0.367 too low. | 157fd16d241ccc7e067127703ae638a4 | 384 | Pfam | PF00261 | Tropomyosin | 175 | 383 | 2.0E-83 | T | 22-09-2020 | IPR000533 | Tropomyosin |
| UnnamedSample_HQ_transcript/868|m.573 | UnnamedSample_HQ_transcript/868 | Coverage 0.224 too low. | f36564706847ad0e49c52ea060a8d814 | 1509 | Pfam | PF10541 | Nuclear envelope localisation domain | 1456 | 1509 | 2.8E-17 | T | 22-09-2020 | IPR012315 | KASH domain |
| UnnamedSample_HQ_transcript/61151|m.16291 | UnnamedSample_HQ_transcript/61151 | Coverage 0.761 too low. | d31090a13e2a4948a429d45e1ccae117 | 486 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 64 | 457 | 1.7E-68 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/75204|m.18883 | UnnamedSample_HQ_transcript/75204 | Identity 0.942 too low. | f3602e27fbd8e0417211d3130412333b | 379 | Pfam | PF00501 | AMP-binding enzyme | 10 | 248 | 1.4E-28 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/115164|m.24413 | UnnamedSample_HQ_transcript/115164 | Coverage 0.152 too low. | 882e1e6351309ce329f85472b9b281bb | 243 | Pfam | PF03920 | Groucho/TLE N-terminal Q-rich domain | 20 | 143 | 2.4E-68 | T | 22-09-2020 | IPR005617 | Groucho/TLE, N-terminal Q-rich domain |
| UnnamedSample_HQ_transcript/71364|m.18183 | UnnamedSample_HQ_transcript/71364 | Coverage 0.138 too low. | 665a5ef0a7d55d901c6d55a9094cda8e | 490 | Pfam | PF00581 | Rhodanese-like domain | 466 | 488 | 1.1E-5 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/77200|m.19240 | UnnamedSample_HQ_transcript/77200 | Coverage 0.142 too low. | 665a5ef0a7d55d901c6d55a9094cda8e | 490 | Pfam | PF00581 | Rhodanese-like domain | 466 | 488 | 1.1E-5 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/64182|m.16879 | UnnamedSample_HQ_transcript/64182 | Coverage 0.527 too low. | 2a64c226f7421416e0518b48b2142132 | 542 | Pfam | PF00084 | Sushi repeat (SCR repeat) | 143 | 188 | 0.0061 | T | 22-09-2020 | IPR000436 | Sushi/SCR/CCP domain |
| UnnamedSample_HQ_transcript/73402|m.18547 | UnnamedSample_HQ_transcript/73402 | Coverage 0.230 too low. | b150a0ff5e48ce6b0c5a910df8665430 | 462 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 7.1E-25 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/63923|m.16828 | UnnamedSample_HQ_transcript/63923 | Coverage 0.734 too low. | fed654749f605dfcc787e466ef5ffe82 | 436 | Pfam | PF05978 | Ion channel regulatory protein UNC-93 | 16 | 164 | 2.9E-28 | T | 22-09-2020 | IPR010291 | Ion channel regulatory protein, UNC-93 |
| UnnamedSample_HQ_transcript/84686|m.20445 | UnnamedSample_HQ_transcript/84686 | Coverage 0.825 too low. | fed654749f605dfcc787e466ef5ffe82 | 436 | Pfam | PF05978 | Ion channel regulatory protein UNC-93 | 16 | 164 | 2.9E-28 | T | 22-09-2020 | IPR010291 | Ion channel regulatory protein, UNC-93 |
| UnnamedSample_HQ_transcript/28808|m.9166 | UnnamedSample_HQ_transcript/28808 | Coverage 0.873 too low. | fed654749f605dfcc787e466ef5ffe82 | 436 | Pfam | PF05978 | Ion channel regulatory protein UNC-93 | 16 | 164 | 2.9E-28 | T | 22-09-2020 | IPR010291 | Ion channel regulatory protein, UNC-93 |
| UnnamedSample_HQ_transcript/75360|m.18913 | UnnamedSample_HQ_transcript/75360 | Coverage 0.845 too low. | fed654749f605dfcc787e466ef5ffe82 | 436 | Pfam | PF05978 | Ion channel regulatory protein UNC-93 | 16 | 164 | 2.9E-28 | T | 22-09-2020 | IPR010291 | Ion channel regulatory protein, UNC-93 |
| UnnamedSample_HQ_transcript/32604|m.10110 | UnnamedSample_HQ_transcript/32604 | Coverage 0.913 too low. | fed654749f605dfcc787e466ef5ffe82 | 436 | Pfam | PF05978 | Ion channel regulatory protein UNC-93 | 16 | 164 | 2.9E-28 | T | 22-09-2020 | IPR010291 | Ion channel regulatory protein, UNC-93 |
| UnnamedSample_HQ_transcript/68549|m.17676 | UnnamedSample_HQ_transcript/68549 | Coverage 0.781 too low. | fed654749f605dfcc787e466ef5ffe82 | 436 | Pfam | PF05978 | Ion channel regulatory protein UNC-93 | 16 | 164 | 2.9E-28 | T | 22-09-2020 | IPR010291 | Ion channel regulatory protein, UNC-93 |
| UnnamedSample_HQ_transcript/27461|m.8823 | UnnamedSample_HQ_transcript/27461 | Coverage 0.885 too low. | fed654749f605dfcc787e466ef5ffe82 | 436 | Pfam | PF05978 | Ion channel regulatory protein UNC-93 | 16 | 164 | 2.9E-28 | T | 22-09-2020 | IPR010291 | Ion channel regulatory protein, UNC-93 |
| UnnamedSample_HQ_transcript/37644|m.11308 | UnnamedSample_HQ_transcript/37644 | Coverage 0.866 too low. | fed654749f605dfcc787e466ef5ffe82 | 436 | Pfam | PF05978 | Ion channel regulatory protein UNC-93 | 16 | 164 | 2.9E-28 | T | 22-09-2020 | IPR010291 | Ion channel regulatory protein, UNC-93 |
| UnnamedSample_HQ_transcript/60228|m.16104 | UnnamedSample_HQ_transcript/60228 | Coverage 0.696 too low. | fed654749f605dfcc787e466ef5ffe82 | 436 | Pfam | PF05978 | Ion channel regulatory protein UNC-93 | 16 | 164 | 2.9E-28 | T | 22-09-2020 | IPR010291 | Ion channel regulatory protein, UNC-93 |
| UnnamedSample_HQ_transcript/36133|m.10964 | UnnamedSample_HQ_transcript/36133 | Coverage 0.803 too low. | 9a4a6b53db1acf85a9f9f1483f49c511 | 247 | Pfam | PF00041 | Fibronectin type III domain | 27 | 111 | 1.0E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/11368|m.4279 | UnnamedSample_HQ_transcript/11368 | Coverage 0.212 too low. | be0cecac1369d1d97680ae3076b37c5e | 1073 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 285 | 459 | 4.5E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/11368|m.4279 | UnnamedSample_HQ_transcript/11368 | Coverage 0.212 too low. | be0cecac1369d1d97680ae3076b37c5e | 1073 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 115 | 184 | 6.7E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/3759|m.1719 | UnnamedSample_HQ_transcript/3759 | Coverage 0.157 too low. | 3df83e0118765e66e7f5cafcfdc91fe9 | 1444 | Pfam | PF02210 | Laminin G domain | 718 | 839 | 3.4E-21 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/3759|m.1719 | UnnamedSample_HQ_transcript/3759 | Coverage 0.157 too low. | 3df83e0118765e66e7f5cafcfdc91fe9 | 1444 | Pfam | PF02210 | Laminin G domain | 1119 | 1245 | 8.3E-23 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/3759|m.1719 | UnnamedSample_HQ_transcript/3759 | Coverage 0.157 too low. | 3df83e0118765e66e7f5cafcfdc91fe9 | 1444 | Pfam | PF02210 | Laminin G domain | 1296 | 1423 | 5.6E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/3759|m.1719 | UnnamedSample_HQ_transcript/3759 | Coverage 0.157 too low. | 3df83e0118765e66e7f5cafcfdc91fe9 | 1444 | Pfam | PF02210 | Laminin G domain | 488 | 650 | 7.7E-15 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/3759|m.1719 | UnnamedSample_HQ_transcript/3759 | Coverage 0.157 too low. | 3df83e0118765e66e7f5cafcfdc91fe9 | 1444 | Pfam | PF02210 | Laminin G domain | 899 | 1018 | 3.4E-12 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/3759|m.1719 | UnnamedSample_HQ_transcript/3759 | Coverage 0.157 too low. | 3df83e0118765e66e7f5cafcfdc91fe9 | 1444 | Pfam | PF06009 | Laminin Domain II | 352 | 474 | 2.1E-9 | T | 22-09-2020 | IPR010307 | Laminin domain II |
| UnnamedSample_HQ_transcript/108022|m.23579 | UnnamedSample_HQ_transcript/108022 | Coverage 0.829 too low. | eb4f7b61ce2e3e5a45ae4798bcdd75af | 201 | Pfam | PF01395 | PBP/GOBP family | 26 | 137 | 5.6E-9 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/106975|m.23458 | UnnamedSample_HQ_transcript/106975 | Coverage 0.804 too low. | eb4f7b61ce2e3e5a45ae4798bcdd75af | 201 | Pfam | PF01395 | PBP/GOBP family | 26 | 137 | 5.6E-9 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/119110|m.24784 | UnnamedSample_HQ_transcript/119110 | Coverage 0.977 too low. | 3b36425edf703e841fda6f5dc3bad1bc | 196 | Pfam | PF00270 | DEAD/DEAH box helicase | 2 | 160 | 3.7E-46 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/107683|m.23544 | UnnamedSample_HQ_transcript/107683 | Coverage 0.467 too low. | 32fc674b5277e8e8479197f6b52fe0a2 | 214 | Pfam | PF08389 | Exportin 1-like protein | 100 | 206 | 4.8E-5 | T | 22-09-2020 | IPR013598 | Exportin-1/Importin-beta-like |
| UnnamedSample_HQ_transcript/7034|m.2872 | UnnamedSample_HQ_transcript/7034 | Coverage 0.862 too low. | b0055ac64e375f71cee58c14871080a4 | 1100 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 48 | 236 | 3.3E-44 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/7034|m.2872 | UnnamedSample_HQ_transcript/7034 | Coverage 0.862 too low. | b0055ac64e375f71cee58c14871080a4 | 1100 | Pfam | PF06367 | Diaphanous FH3 Domain | 239 | 426 | 1.4E-58 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/7034|m.2872 | UnnamedSample_HQ_transcript/7034 | Coverage 0.862 too low. | b0055ac64e375f71cee58c14871080a4 | 1100 | Pfam | PF02181 | Formin Homology 2 Domain | 611 | 985 | 9.4E-111 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/104852|m.23214 | UnnamedSample_HQ_transcript/104852 | Coverage 0.531 too low. | 066121d5f8f380272c45e4ef0450dc0f | 236 | Pfam | PF05721 | Phytanoyl-CoA dioxygenase (PhyH) | 29 | 178 | 7.3E-35 | T | 22-09-2020 | IPR008775 | Phytanoyl-CoA dioxygenase |
| UnnamedSample_HQ_transcript/78571|m.19474 | UnnamedSample_HQ_transcript/78571 | Coverage 0.988 too low. | 06d40f20a3a26667f56fb34b34a8855c | 287 | Pfam | PF01608 | I/LWEQ domain | 131 | 279 | 6.3E-56 | T | 22-09-2020 | IPR002558 | I/LWEQ domain |
| UnnamedSample_HQ_transcript/46296|m.13211 | UnnamedSample_HQ_transcript/46296 | Coverage 0.265 too low. | 1581896c05aefb5bce0b702ebf6e58c2 | 697 | Pfam | PF04389 | Peptidase family M28 | 1 | 154 | 2.2E-18 | T | 22-09-2020 | IPR007484 | Peptidase M28 |
| UnnamedSample_HQ_transcript/8701|m.3414 | UnnamedSample_HQ_transcript/8701 | Coverage 0.021 too low. | 66fe6e69edcd7dd9ccd678c669877e42 | 561 | Pfam | PF13246 | Cation transport ATPase (P-type) | 2 | 40 | 9.1E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8701|m.3414 | UnnamedSample_HQ_transcript/8701 | Coverage 0.021 too low. | 66fe6e69edcd7dd9ccd678c669877e42 | 561 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 287 | 535 | 6.5E-75 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/25609|m.8372 | UnnamedSample_HQ_transcript/25609 | Coverage 0.960 too low. | 720258248e761de99e8bdfcc6b0aeeef | 649 | Pfam | PF11838 | ERAP1-like C-terminal domain | 260 | 535 | 5.4E-46 | T | 22-09-2020 | IPR024571 | ERAP1-like C-terminal domain |
| UnnamedSample_HQ_transcript/25609|m.8372 | UnnamedSample_HQ_transcript/25609 | Coverage 0.960 too low. | 720258248e761de99e8bdfcc6b0aeeef | 649 | Pfam | PF01433 | Peptidase family M1 domain | 8 | 180 | 6.3E-21 | T | 22-09-2020 | IPR014782 | Peptidase M1, membrane alanine aminopeptidase |
| UnnamedSample_HQ_transcript/84706|m.20449 | UnnamedSample_HQ_transcript/84706 | Coverage 0.393 too low. | 7d1d76149eaedde165f0ef163628d45b | 282 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 1 | 217 | 3.6E-18 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/8197|m.3255 | UnnamedSample_HQ_transcript/8197 | Identity 0.912 too low. | 6b867fb1b8bea32f4e05aa419254e288 | 381 | Pfam | PF00069 | Protein kinase domain | 105 | 342 | 4.9E-20 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/63811|m.16804 | UnnamedSample_HQ_transcript/63811 | Coverage 0.183 too low. | 5d17c45a1e96031afc0f9d094391395d | 427 | Pfam | PF00012 | Hsp70 protein | 3 | 289 | 1.8E-21 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/54071|m.14851 | UnnamedSample_HQ_transcript/54071 | Identity 0.767 too low. | 5d17c45a1e96031afc0f9d094391395d | 427 | Pfam | PF00012 | Hsp70 protein | 3 | 289 | 1.8E-21 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/33269|m.10280 | UnnamedSample_HQ_transcript/33269 | Coverage 0.934 too low. | 42f88cbf9dcfa758c240261ba9aa6201 | 734 | Pfam | PF00307 | Calponin homology (CH) domain | 532 | 634 | 8.0E-16 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/33269|m.10280 | UnnamedSample_HQ_transcript/33269 | Coverage 0.934 too low. | 42f88cbf9dcfa758c240261ba9aa6201 | 734 | Pfam | PF00890 | FAD binding domain | 97 | 128 | 8.2E-6 | T | 22-09-2020 | IPR003953 | FAD-dependent oxidoreductase 2, FAD binding domain |
| UnnamedSample_HQ_transcript/13319|m.4892 | UnnamedSample_HQ_transcript/13319 | Unmapped. | 1ab6e4db80480481357c240d14f45339 | 1219 | Pfam | PF00910 | RNA helicase | 839 | 947 | 4.1E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/13319|m.4892 | UnnamedSample_HQ_transcript/13319 | Unmapped. | 1ab6e4db80480481357c240d14f45339 | 1219 | Pfam | PF08762 | CRPV capsid protein like | 215 | 425 | 5.9E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/92421|m.21594 | UnnamedSample_HQ_transcript/92421 | Coverage 0.651 too low. | 8fc3ff7d7e2958a54ba432048a53b396 | 225 | Pfam | PF01061 | ABC-2 type transporter | 3 | 162 | 4.6E-36 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/83510|m.20265 | UnnamedSample_HQ_transcript/83510 | Coverage 0.185 too low. | 094c8baf9c69b8899bff721fd64c3233 | 263 | Pfam | PF00907 | T-box | 1 | 65 | 7.9E-24 | T | 22-09-2020 | IPR001699 | Transcription factor, T-box |
| UnnamedSample_HQ_transcript/35339|m.10785 | UnnamedSample_HQ_transcript/35339 | Unmapped. | 793b481837a74f6881724c2d7fe1134f | 784 | Pfam | PF00910 | RNA helicase | 55 | 163 | 2.2E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/18164|m.6357 | UnnamedSample_HQ_transcript/18164 | Coverage 0.988 too low. | ccbb8d488f44e4118d4e92404bf0f595 | 557 | Pfam | PF12874 | Zinc-finger of C2H2 type | 418 | 442 | 0.017 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/18164|m.6357 | UnnamedSample_HQ_transcript/18164 | Coverage 0.988 too low. | ccbb8d488f44e4118d4e92404bf0f595 | 557 | Pfam | PF12874 | Zinc-finger of C2H2 type | 464 | 488 | 0.03 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/18164|m.6357 | UnnamedSample_HQ_transcript/18164 | Coverage 0.988 too low. | ccbb8d488f44e4118d4e92404bf0f595 | 557 | Pfam | PF00096 | Zinc finger, C2H2 type | 65 | 89 | 0.0012 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/18164|m.6357 | UnnamedSample_HQ_transcript/18164 | Coverage 0.988 too low. | ccbb8d488f44e4118d4e92404bf0f595 | 557 | Pfam | PF00096 | Zinc finger, C2H2 type | 37 | 59 | 9.9E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/18164|m.6357 | UnnamedSample_HQ_transcript/18164 | Coverage 0.988 too low. | ccbb8d488f44e4118d4e92404bf0f595 | 557 | Pfam | PF00096 | Zinc finger, C2H2 type | 391 | 412 | 9.2E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24557|m.8089 | UnnamedSample_HQ_transcript/24557 | Coverage 0.327 too low. | eace309188bb9c7a65a1bfde0742b406 | 884 | Pfam | PF13855 | Leucine rich repeat | 179 | 236 | 1.4E-9 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/24557|m.8089 | UnnamedSample_HQ_transcript/24557 | Coverage 0.327 too low. | eace309188bb9c7a65a1bfde0742b406 | 884 | Pfam | PF13516 | Leucine Rich repeat | 107 | 120 | 1.2 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/24557|m.8089 | UnnamedSample_HQ_transcript/24557 | Coverage 0.327 too low. | eace309188bb9c7a65a1bfde0742b406 | 884 | Pfam | PF00481 | Protein phosphatase 2C | 552 | 614 | 2.7E-7 | T | 22-09-2020 | IPR001932 | PPM-type phosphatase domain |
| UnnamedSample_HQ_transcript/89524|m.21165 | UnnamedSample_HQ_transcript/89524 | Coverage 0.952 too low. | d20ff6f256d8ac6ac64ce7b503ca34c6 | 380 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.1E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/81540|m.19959 | UnnamedSample_HQ_transcript/81540 | Coverage 0.367 too low. | 36662021eae2e7bc09d75ca7410d5a71 | 183 | Pfam | PF08347 | N-terminal CTNNB1 binding | 6 | 65 | 1.5E-6 | T | 22-09-2020 | IPR013558 | CTNNB1 binding, N-teminal |
| UnnamedSample_HQ_transcript/83321|m.20242 | UnnamedSample_HQ_transcript/83321 | Coverage 0.762 too low. | 9a43ad793de45609694f629717ec666f | 322 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 72 | 309 | 4.6E-89 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/54069|m.14850 | UnnamedSample_HQ_transcript/54069 | Coverage 0.200 too low. | 0f8aa0a300d0a5dc209fe258ebc5a14c | 495 | Pfam | PF00017 | SH2 domain | 362 | 442 | 6.7E-12 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/54069|m.14850 | UnnamedSample_HQ_transcript/54069 | Coverage 0.200 too low. | 0f8aa0a300d0a5dc209fe258ebc5a14c | 495 | Pfam | PF00640 | Phosphotyrosine interaction domain (PTB/PID) | 27 | 131 | 1.0E-10 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/89214|m.21113 | UnnamedSample_HQ_transcript/89214 | Coverage 0.156 too low. | d876278b165426249c65affa9ab8c2d2 | 293 | Pfam | PF00650 | CRAL/TRIO domain | 110 | 263 | 2.9E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/78664|m.19494 | UnnamedSample_HQ_transcript/78664 | Coverage 0.257 too low. | d876278b165426249c65affa9ab8c2d2 | 293 | Pfam | PF00650 | CRAL/TRIO domain | 110 | 263 | 2.9E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/83965|m.20334 | UnnamedSample_HQ_transcript/83965 | Coverage 0.187 too low. | d876278b165426249c65affa9ab8c2d2 | 293 | Pfam | PF00650 | CRAL/TRIO domain | 110 | 263 | 2.9E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/86370|m.20703 | UnnamedSample_HQ_transcript/86370 | Coverage 0.194 too low. | d876278b165426249c65affa9ab8c2d2 | 293 | Pfam | PF00650 | CRAL/TRIO domain | 110 | 263 | 2.9E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/85261|m.20537 | UnnamedSample_HQ_transcript/85261 | Coverage 0.951 too low. | 045ab33b52a5e9df9abac9c6b7d541ae | 431 | Pfam | PF00630 | Filamin/ABP280 repeat | 123 | 197 | 6.6E-9 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/85261|m.20537 | UnnamedSample_HQ_transcript/85261 | Coverage 0.951 too low. | 045ab33b52a5e9df9abac9c6b7d541ae | 431 | Pfam | PF00630 | Filamin/ABP280 repeat | 293 | 377 | 8.4E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/28648|m.9127 | UnnamedSample_HQ_transcript/28648 | Coverage 0.925 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 577 | 604 | 2.8E-7 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/28648|m.9127 | UnnamedSample_HQ_transcript/28648 | Coverage 0.925 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 766 | 793 | 4.5E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/28648|m.9127 | UnnamedSample_HQ_transcript/28648 | Coverage 0.925 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 530 | 557 | 1.4E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/28648|m.9127 | UnnamedSample_HQ_transcript/28648 | Coverage 0.925 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF08450 | SMP-30/Gluconolactonase/LRE-like region | 629 | 756 | 2.9E-10 | T | 22-09-2020 | IPR013658 | SMP-30/Gluconolactonase/LRE-like region |
| UnnamedSample_HQ_transcript/24736|m.8147 | UnnamedSample_HQ_transcript/24736 | Coverage 0.942 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 577 | 604 | 2.8E-7 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/24736|m.8147 | UnnamedSample_HQ_transcript/24736 | Coverage 0.942 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 766 | 793 | 4.5E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/24736|m.8147 | UnnamedSample_HQ_transcript/24736 | Coverage 0.942 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 530 | 557 | 1.4E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/24736|m.8147 | UnnamedSample_HQ_transcript/24736 | Coverage 0.942 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF08450 | SMP-30/Gluconolactonase/LRE-like region | 629 | 756 | 2.9E-10 | T | 22-09-2020 | IPR013658 | SMP-30/Gluconolactonase/LRE-like region |
| UnnamedSample_HQ_transcript/25118|m.8248 | UnnamedSample_HQ_transcript/25118 | Coverage 0.939 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 577 | 604 | 2.8E-7 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/25118|m.8248 | UnnamedSample_HQ_transcript/25118 | Coverage 0.939 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 766 | 793 | 4.5E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/25118|m.8248 | UnnamedSample_HQ_transcript/25118 | Coverage 0.939 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 530 | 557 | 1.4E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/25118|m.8248 | UnnamedSample_HQ_transcript/25118 | Coverage 0.939 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF08450 | SMP-30/Gluconolactonase/LRE-like region | 629 | 756 | 2.9E-10 | T | 22-09-2020 | IPR013658 | SMP-30/Gluconolactonase/LRE-like region |
| UnnamedSample_HQ_transcript/27112|m.8749 | UnnamedSample_HQ_transcript/27112 | Coverage 0.927 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 577 | 604 | 2.8E-7 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/27112|m.8749 | UnnamedSample_HQ_transcript/27112 | Coverage 0.927 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 766 | 793 | 4.5E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/27112|m.8749 | UnnamedSample_HQ_transcript/27112 | Coverage 0.927 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF01436 | NHL repeat | 530 | 557 | 1.4E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/27112|m.8749 | UnnamedSample_HQ_transcript/27112 | Coverage 0.927 too low. | 904d6438f10e18014b93343bfd95f74e | 793 | Pfam | PF08450 | SMP-30/Gluconolactonase/LRE-like region | 629 | 756 | 2.9E-10 | T | 22-09-2020 | IPR013658 | SMP-30/Gluconolactonase/LRE-like region |
| UnnamedSample_HQ_transcript/36297|m.11003 | UnnamedSample_HQ_transcript/36297 | Coverage 0.570 too low. | f3919f2e3ee953d1369c4d621fc55592 | 542 | Pfam | PF00135 | Carboxylesterase family | 2 | 521 | 5.0E-135 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/40555|m.11973 | UnnamedSample_HQ_transcript/40555 | Coverage 0.625 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 388 | 409 | 0.0046 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/40555|m.11973 | UnnamedSample_HQ_transcript/40555 | Coverage 0.625 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 415 | 438 | 3.8E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/40555|m.11973 | UnnamedSample_HQ_transcript/40555 | Coverage 0.625 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 277 | 298 | 0.0039 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/40555|m.11973 | UnnamedSample_HQ_transcript/40555 | Coverage 0.625 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00651 | BTB/POZ domain | 24 | 121 | 3.6E-16 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/45114|m.12935 | UnnamedSample_HQ_transcript/45114 | Coverage 0.604 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 388 | 409 | 0.0046 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/45114|m.12935 | UnnamedSample_HQ_transcript/45114 | Coverage 0.604 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 415 | 438 | 3.8E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/45114|m.12935 | UnnamedSample_HQ_transcript/45114 | Coverage 0.604 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 277 | 298 | 0.0039 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/45114|m.12935 | UnnamedSample_HQ_transcript/45114 | Coverage 0.604 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00651 | BTB/POZ domain | 24 | 121 | 3.6E-16 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/48846|m.13768 | UnnamedSample_HQ_transcript/48846 | Coverage 0.874 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 388 | 409 | 0.0046 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/48846|m.13768 | UnnamedSample_HQ_transcript/48846 | Coverage 0.874 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 415 | 438 | 3.8E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/48846|m.13768 | UnnamedSample_HQ_transcript/48846 | Coverage 0.874 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 277 | 298 | 0.0039 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/48846|m.13768 | UnnamedSample_HQ_transcript/48846 | Coverage 0.874 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00651 | BTB/POZ domain | 24 | 121 | 3.6E-16 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/57410|m.15526 | UnnamedSample_HQ_transcript/57410 | Coverage 0.916 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 388 | 409 | 0.0046 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/57410|m.15526 | UnnamedSample_HQ_transcript/57410 | Coverage 0.916 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 415 | 438 | 3.8E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/57410|m.15526 | UnnamedSample_HQ_transcript/57410 | Coverage 0.916 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00096 | Zinc finger, C2H2 type | 277 | 298 | 0.0039 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/57410|m.15526 | UnnamedSample_HQ_transcript/57410 | Coverage 0.916 too low. | dbffd897d477a86376ed73c128ddce67 | 449 | Pfam | PF00651 | BTB/POZ domain | 24 | 121 | 3.6E-16 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/98506|m.22434 | UnnamedSample_HQ_transcript/98506 | Coverage 0.541 too low. | 2805724daafb7cbb45320f780a9a9a7f | 350 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 151 | 276 | 2.1E-15 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/98506|m.22434 | UnnamedSample_HQ_transcript/98506 | Coverage 0.541 too low. | 2805724daafb7cbb45320f780a9a9a7f | 350 | Pfam | PF02148 | Zn-finger in ubiquitin-hydrolases and other protein | 50 | 111 | 5.5E-12 | T | 22-09-2020 | IPR001607 | Zinc finger, UBP-type |
| UnnamedSample_HQ_transcript/56132|m.15264 | UnnamedSample_HQ_transcript/56132 | Unmapped. | d19a968c68fb5cbde788df5fc1fe58ba | 411 | Pfam | PF07724 | AAA domain (Cdc48 subfamily) | 355 | 411 | 8.9E-16 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/56132|m.15264 | UnnamedSample_HQ_transcript/56132 | Unmapped. | d19a968c68fb5cbde788df5fc1fe58ba | 411 | Pfam | PF17871 | AAA lid domain | 102 | 201 | 3.3E-34 | T | 22-09-2020 | IPR041546 | ClpA/ClpB, AAA lid domain |
| UnnamedSample_HQ_transcript/56132|m.15264 | UnnamedSample_HQ_transcript/56132 | Unmapped. | d19a968c68fb5cbde788df5fc1fe58ba | 411 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 8 | 96 | 7.3E-6 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/41804|m.12222 | UnnamedSample_HQ_transcript/41804 | Coverage 0.980 too low. | b42292bf1769bb54708c28402fb30905 | 716 | Pfam | PF17855 | MCM AAA-lid domain | 525 | 609 | 4.4E-30 | T | 22-09-2020 | IPR041562 | MCM, AAA-lid domain |
| UnnamedSample_HQ_transcript/41804|m.12222 | UnnamedSample_HQ_transcript/41804 | Coverage 0.980 too low. | b42292bf1769bb54708c28402fb30905 | 716 | Pfam | PF00493 | MCM P-loop domain | 274 | 496 | 3.1E-100 | T | 22-09-2020 | IPR001208 | MCM domain |
| UnnamedSample_HQ_transcript/41804|m.12222 | UnnamedSample_HQ_transcript/41804 | Coverage 0.980 too low. | b42292bf1769bb54708c28402fb30905 | 716 | Pfam | PF17207 | MCM OB domain | 107 | 234 | 8.1E-37 | T | 22-09-2020 | IPR033762 | MCM OB domain |
| UnnamedSample_HQ_transcript/41804|m.12222 | UnnamedSample_HQ_transcript/41804 | Coverage 0.980 too low. | b42292bf1769bb54708c28402fb30905 | 716 | Pfam | PF14551 | MCM N-terminal domain | 10 | 98 | 1.3E-17 | T | 22-09-2020 | IPR027925 | MCM N-terminal domain |
| UnnamedSample_HQ_transcript/29802|m.9424 | UnnamedSample_HQ_transcript/29802 | Coverage 0.167 too low. | 31c21d08f78a450fe80a96556b794e55 | 852 | Pfam | PF00169 | PH domain | 334 | 429 | 1.4E-12 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/29802|m.9424 | UnnamedSample_HQ_transcript/29802 | Coverage 0.167 too low. | 31c21d08f78a450fe80a96556b794e55 | 852 | Pfam | PF00169 | PH domain | 51 | 149 | 1.1E-11 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/63289|m.16690 | UnnamedSample_HQ_transcript/63289 | Coverage 0.962 too low. | c51ecbd419e1ecf5b490bf7afa18db94 | 515 | Pfam | PF00651 | BTB/POZ domain | 22 | 119 | 1.8E-25 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/97191|m.22262 | UnnamedSample_HQ_transcript/97191 | Coverage 0.780 too low. | 9a8b351352398d24442209158afad34c | 269 | Pfam | PF02893 | GRAM domain | 37 | 128 | 1.5E-11 | T | 22-09-2020 | IPR004182 | GRAM domain |
| UnnamedSample_HQ_transcript/73540|m.18578 | UnnamedSample_HQ_transcript/73540 | Coverage 0.842 too low. | 9a8b351352398d24442209158afad34c | 269 | Pfam | PF02893 | GRAM domain | 37 | 128 | 1.5E-11 | T | 22-09-2020 | IPR004182 | GRAM domain |
| UnnamedSample_HQ_transcript/93892|m.21796 | UnnamedSample_HQ_transcript/93892 | Coverage 0.741 too low. | 9a8b351352398d24442209158afad34c | 269 | Pfam | PF02893 | GRAM domain | 37 | 128 | 1.5E-11 | T | 22-09-2020 | IPR004182 | GRAM domain |
| UnnamedSample_HQ_transcript/64212|m.16891 | UnnamedSample_HQ_transcript/64212 | Coverage 0.378 too low. | 9a8b351352398d24442209158afad34c | 269 | Pfam | PF02893 | GRAM domain | 37 | 128 | 1.5E-11 | T | 22-09-2020 | IPR004182 | GRAM domain |
| UnnamedSample_HQ_transcript/38790|m.11573 | UnnamedSample_HQ_transcript/38790 | Coverage 0.606 too low. | 240567970424f10231608bc8f66ff4a4 | 320 | Pfam | PF00017 | SH2 domain | 178 | 259 | 5.4E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/10211|m.3894 | UnnamedSample_HQ_transcript/10211 | Identity 0.770 too low. | bb37a977ad56724ce7517f8d1d2953bf | 799 | Pfam | PF04849 | HAP1 N-terminal conserved region | 1 | 237 | 1.0E-65 | T | 22-09-2020 | IPR006933 | HAP1, N-terminal |
| UnnamedSample_HQ_transcript/10211|m.3894 | UnnamedSample_HQ_transcript/10211 | Identity 0.770 too low. | bb37a977ad56724ce7517f8d1d2953bf | 799 | Pfam | PF12448 | Kinesin associated protein | 312 | 456 | 4.1E-20 | T | 22-09-2020 | IPR022154 | Trafficking kinesin-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/72363|m.18361 | UnnamedSample_HQ_transcript/72363 | Coverage 0.859 too low. | ff5f87afb0202be40397060541dc727c | 542 | Pfam | PF00307 | Calponin homology (CH) domain | 151 | 254 | 4.4E-21 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/72363|m.18361 | UnnamedSample_HQ_transcript/72363 | Coverage 0.859 too low. | ff5f87afb0202be40397060541dc727c | 542 | Pfam | PF00307 | Calponin homology (CH) domain | 35 | 137 | 3.7E-24 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/56883|m.15422 | UnnamedSample_HQ_transcript/56883 | Coverage 0.719 too low. | ff5f87afb0202be40397060541dc727c | 542 | Pfam | PF00307 | Calponin homology (CH) domain | 151 | 254 | 4.4E-21 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/56883|m.15422 | UnnamedSample_HQ_transcript/56883 | Coverage 0.719 too low. | ff5f87afb0202be40397060541dc727c | 542 | Pfam | PF00307 | Calponin homology (CH) domain | 35 | 137 | 3.7E-24 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/84084|m.20352 | UnnamedSample_HQ_transcript/84084 | Coverage 0.560 too low. | 384f6cb7f3cf13ab8196aa30da58cea1 | 364 | Pfam | PF12874 | Zinc-finger of C2H2 type | 238 | 256 | 0.02 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7640|m.3068 | UnnamedSample_HQ_transcript/7640 | Coverage 0.989 too low. | 8f339a76eb5d7cdb6a47077e83709981 | 557 | Pfam | PF00135 | Carboxylesterase family | 8 | 539 | 1.7E-115 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/106882|m.23442 | UnnamedSample_HQ_transcript/106882 | Coverage 0.246 too low. | 422284de5e7850eb0af09ab02366b605 | 223 | Pfam | PF00244 | 14-3-3 protein | 1 | 208 | 2.7E-102 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/27657|m.8873 | UnnamedSample_HQ_transcript/27657 | Coverage 0.789 too low. | accccf3e17d69416a177ec6b6c3cd2bf | 771 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 355 | 405 | 8.9E-13 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/50060|m.14036 | UnnamedSample_HQ_transcript/50060 | Coverage 0.960 too low. | 6ef3019fda6d33504faf767011065028 | 261 | Pfam | PF00002 | 7 transmembrane receptor (Secretin family) | 19 | 208 | 6.5E-18 | T | 22-09-2020 | IPR000832 | GPCR, family 2, secretin-like |
| UnnamedSample_HQ_transcript/14926|m.5381 | UnnamedSample_HQ_transcript/14926 | Coverage 0.047 too low. | 50128e05b2277a434e213f2707d756d3 | 731 | Pfam | PF01074 | Glycosyl hydrolases family 38 N-terminal domain | 124 | 448 | 2.6E-99 | T | 22-09-2020 | IPR000602 | Glycoside hydrolase family 38, N-terminal domain |
| UnnamedSample_HQ_transcript/14926|m.5381 | UnnamedSample_HQ_transcript/14926 | Coverage 0.047 too low. | 50128e05b2277a434e213f2707d756d3 | 731 | Pfam | PF09261 | Alpha mannosidase middle domain | 454 | 558 | 3.1E-24 | T | 22-09-2020 | IPR015341 | Glycoside hydrolase family 38, central domain |
| UnnamedSample_HQ_transcript/101179|m.22773 | UnnamedSample_HQ_transcript/101179 | Coverage 0.095 too low. | a9b47c707de747df609b42902f160076 | 271 | Pfam | PF03366 | YEATS family | 28 | 108 | 6.9E-25 | T | 22-09-2020 | IPR005033 | YEATS |
| UnnamedSample_HQ_transcript/108983|m.23710 | UnnamedSample_HQ_transcript/108983 | Coverage 0.574 too low. | a9b47c707de747df609b42902f160076 | 271 | Pfam | PF03366 | YEATS family | 28 | 108 | 6.9E-25 | T | 22-09-2020 | IPR005033 | YEATS |
| UnnamedSample_HQ_transcript/32084|m.9971 | UnnamedSample_HQ_transcript/32084 | Coverage 0.670 too low. | 9148852b60217f4a441c8c51ec172052 | 745 | Pfam | PF01476 | LysM domain | 219 | 261 | 5.2E-9 | T | 22-09-2020 | IPR018392 | LysM domain |
| UnnamedSample_HQ_transcript/35383|m.10798 | UnnamedSample_HQ_transcript/35383 | Coverage 0.694 too low. | 9148852b60217f4a441c8c51ec172052 | 745 | Pfam | PF01476 | LysM domain | 219 | 261 | 5.2E-9 | T | 22-09-2020 | IPR018392 | LysM domain |
| UnnamedSample_HQ_transcript/10058|m.3852 | UnnamedSample_HQ_transcript/10058 | Unmapped. | 96f513ed8fc10bdd3e155b37ef0d717f | 1215 | Pfam | PF08762 | CRPV capsid protein like | 942 | 1152 | 5.9E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/15901|m.5677 | UnnamedSample_HQ_transcript/15901 | Identity 0.943 too low. | 679aa68a50c4315f51d31d75481a3b5d | 370 | Pfam | PF05499 | DNA methyltransferase 1-associated protein 1 (DMAP1) | 243 | 353 | 1.9E-38 | T | 22-09-2020 | IPR008468 | DNA methyltransferase 1-associated 1 |
| UnnamedSample_HQ_transcript/15901|m.5677 | UnnamedSample_HQ_transcript/15901 | Identity 0.943 too low. | 679aa68a50c4315f51d31d75481a3b5d | 370 | Pfam | PF16282 | SANT/Myb-like domain of DAMP1 | 123 | 201 | 3.3E-33 | T | 22-09-2020 | IPR032563 | DAMP1, SANT/Myb-like domain |
| UnnamedSample_HQ_transcript/25524|m.8350 | UnnamedSample_HQ_transcript/25524 | Coverage 0.453 too low. | c2e07d59834004319bac4c51c475e64e | 354 | Pfam | PF00615 | Regulator of G protein signaling domain | 4 | 34 | 1.5E-6 | T | 22-09-2020 | IPR016137 | RGS domain |
| UnnamedSample_HQ_transcript/25524|m.8350 | UnnamedSample_HQ_transcript/25524 | Coverage 0.453 too low. | c2e07d59834004319bac4c51c475e64e | 354 | Pfam | PF02196 | Raf-like Ras-binding domain | 202 | 267 | 5.9E-6 | T | 22-09-2020 | IPR003116 | Raf-like Ras-binding |
| UnnamedSample_HQ_transcript/25524|m.8350 | UnnamedSample_HQ_transcript/25524 | Coverage 0.453 too low. | c2e07d59834004319bac4c51c475e64e | 354 | Pfam | PF02196 | Raf-like Ras-binding domain | 130 | 197 | 7.7E-14 | T | 22-09-2020 | IPR003116 | Raf-like Ras-binding |
| UnnamedSample_HQ_transcript/74521|m.18743 | UnnamedSample_HQ_transcript/74521 | Coverage 0.284 too low. | 6e5034fc7ae0a8bb9cac751906618e1a | 454 | Pfam | PF02845 | CUE domain | 205 | 243 | 3.0E-8 | T | 22-09-2020 | IPR003892 | Ubiquitin system component CUE |
| UnnamedSample_HQ_transcript/6648|m.2761 | UnnamedSample_HQ_transcript/6648 | Coverage 0.915 too low. | 03c5ef9e83836e8194de411203fe76f0 | 805 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.8E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6648|m.2761 | UnnamedSample_HQ_transcript/6648 | Coverage 0.915 too low. | 03c5ef9e83836e8194de411203fe76f0 | 805 | Pfam | PF13927 | Immunoglobulin domain | 393 | 457 | 2.4E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6648|m.2761 | UnnamedSample_HQ_transcript/6648 | Coverage 0.915 too low. | 03c5ef9e83836e8194de411203fe76f0 | 805 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.8E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6648|m.2761 | UnnamedSample_HQ_transcript/6648 | Coverage 0.915 too low. | 03c5ef9e83836e8194de411203fe76f0 | 805 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 1.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/6648|m.2761 | UnnamedSample_HQ_transcript/6648 | Coverage 0.915 too low. | 03c5ef9e83836e8194de411203fe76f0 | 805 | Pfam | PF00041 | Fibronectin type III domain | 476 | 559 | 5.6E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6648|m.2761 | UnnamedSample_HQ_transcript/6648 | Coverage 0.915 too low. | 03c5ef9e83836e8194de411203fe76f0 | 805 | Pfam | PF00041 | Fibronectin type III domain | 593 | 677 | 7.4E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6801|m.2798 | UnnamedSample_HQ_transcript/6801 | Coverage 0.916 too low. | 11a0681abd75257b66e58d131ec3bacf | 670 | Pfam | PF01429 | Methyl-CpG binding domain | 58 | 120 | 5.1E-8 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/3865|m.1759 | UnnamedSample_HQ_transcript/3865 | Unmapped. | 0011bfe7eab8989122a3753b0fc53018 | 1676 | Pfam | PF00910 | RNA helicase | 1297 | 1405 | 6.1E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/3865|m.1759 | UnnamedSample_HQ_transcript/3865 | Unmapped. | 0011bfe7eab8989122a3753b0fc53018 | 1676 | Pfam | PF08762 | CRPV capsid protein like | 673 | 883 | 9.5E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/81586|m.19967 | UnnamedSample_HQ_transcript/81586 | Coverage 0.111 too low. | d95814221c5235b1ff4563607fd2b423 | 184 | Pfam | PF00335 | Tetraspanin family | 92 | 172 | 7.2E-8 | T | 22-09-2020 | IPR018499 | Tetraspanin/Peripherin |
| UnnamedSample_HQ_transcript/111939|m.24068 | UnnamedSample_HQ_transcript/111939 | Coverage 0.488 too low. | d89dc716b41d9e6f1ea9b919079cb90d | 141 | Pfam | PF05835 | Synaphin protein | 2 | 131 | 1.9E-41 | T | 22-09-2020 | IPR008849 | Synaphin |
| UnnamedSample_HQ_transcript/24860|m.8182 | UnnamedSample_HQ_transcript/24860 | Coverage 0.315 too low. | d89dc716b41d9e6f1ea9b919079cb90d | 141 | Pfam | PF05835 | Synaphin protein | 2 | 131 | 1.9E-41 | T | 22-09-2020 | IPR008849 | Synaphin |
| UnnamedSample_HQ_transcript/57203|m.15487 | UnnamedSample_HQ_transcript/57203 | Coverage 0.467 too low. | d89dc716b41d9e6f1ea9b919079cb90d | 141 | Pfam | PF05835 | Synaphin protein | 2 | 131 | 1.9E-41 | T | 22-09-2020 | IPR008849 | Synaphin |
| UnnamedSample_HQ_transcript/17213|m.6070 | UnnamedSample_HQ_transcript/17213 | Coverage 0.163 too low. | 9af3f6da75452b8a03243d2e39e45189 | 594 | Pfam | PF00615 | Regulator of G protein signaling domain | 58 | 176 | 1.4E-11 | T | 22-09-2020 | IPR016137 | RGS domain |
| UnnamedSample_HQ_transcript/17213|m.6070 | UnnamedSample_HQ_transcript/17213 | Coverage 0.163 too low. | 9af3f6da75452b8a03243d2e39e45189 | 594 | Pfam | PF00069 | Protein kinase domain | 194 | 457 | 1.0E-64 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/16827|m.5948 | UnnamedSample_HQ_transcript/16827 | Identity 0.940 too low. | 1ee7fc13c645386a349bb2f06aa1e3b2 | 563 | Pfam | PF02878 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain I | 16 | 156 | 1.2E-35 | T | 22-09-2020 | IPR005844 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain I |
| UnnamedSample_HQ_transcript/16827|m.5948 | UnnamedSample_HQ_transcript/16827 | Identity 0.940 too low. | 1ee7fc13c645386a349bb2f06aa1e3b2 | 563 | Pfam | PF02879 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain II | 205 | 298 | 2.2E-16 | T | 22-09-2020 | IPR005845 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain II |
| UnnamedSample_HQ_transcript/16827|m.5948 | UnnamedSample_HQ_transcript/16827 | Identity 0.940 too low. | 1ee7fc13c645386a349bb2f06aa1e3b2 | 563 | Pfam | PF00408 | Phosphoglucomutase/phosphomannomutase, C-terminal domain | 472 | 537 | 9.0E-7 | T | 22-09-2020 | IPR005843 | Alpha-D-phosphohexomutase, C-terminal |
| UnnamedSample_HQ_transcript/16827|m.5948 | UnnamedSample_HQ_transcript/16827 | Identity 0.940 too low. | 1ee7fc13c645386a349bb2f06aa1e3b2 | 563 | Pfam | PF02880 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain III | 308 | 421 | 9.4E-27 | T | 22-09-2020 | IPR005846 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain III |
| UnnamedSample_HQ_transcript/95315|m.22001 | UnnamedSample_HQ_transcript/95315 | Coverage 0.764 too low. | e7c10f1d9ab3e2c269d410775e053c3d | 181 | Pfam | PF01431 | Peptidase family M13 | 84 | 175 | 6.6E-35 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/6483|m.2700 | UnnamedSample_HQ_transcript/6483 | Coverage 0.871 too low. | e191f352605decb36a307f16ce0605b0 | 324 | Pfam | PF00611 | Fes/CIP4, and EFC/F-BAR homology domain | 1 | 75 | 3.3E-14 | T | 22-09-2020 | IPR001060 | FCH domain |
| UnnamedSample_HQ_transcript/41557|m.12170 | UnnamedSample_HQ_transcript/41557 | Identity 0.910 too low. | 4522a96ec1333a6cd3b2a32174b24405 | 513 | Pfam | PF19055 | ABC-2 type transporter | 117 | 184 | 2.4E-10 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/41557|m.12170 | UnnamedSample_HQ_transcript/41557 | Identity 0.910 too low. | 4522a96ec1333a6cd3b2a32174b24405 | 513 | Pfam | PF01061 | ABC-2 type transporter | 241 | 450 | 1.4E-47 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/29621|m.9387 | UnnamedSample_HQ_transcript/29621 | Coverage 0.980 too low. | dce23f7351cf6743797352b6e5f3e3ce | 531 | Pfam | PF02781 | Glucose-6-phosphate dehydrogenase, C-terminal domain | 228 | 519 | 8.9E-116 | T | 22-09-2020 | IPR022675 | Glucose-6-phosphate dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/29621|m.9387 | UnnamedSample_HQ_transcript/29621 | Coverage 0.980 too low. | dce23f7351cf6743797352b6e5f3e3ce | 531 | Pfam | PF00479 | Glucose-6-phosphate dehydrogenase, NAD binding domain | 51 | 226 | 5.6E-60 | T | 22-09-2020 | IPR022674 | Glucose-6-phosphate dehydrogenase, NAD-binding |
| UnnamedSample_HQ_transcript/45858|m.13109 | UnnamedSample_HQ_transcript/45858 | Coverage 0.960 too low. | d097c6b0b161d4ca3cf2929180e827f2 | 231 | Pfam | PF09379 | FERM N-terminal domain | 9 | 70 | 1.2E-15 | T | 22-09-2020 | IPR018979 | FERM, N-terminal |
| UnnamedSample_HQ_transcript/45858|m.13109 | UnnamedSample_HQ_transcript/45858 | Coverage 0.960 too low. | d097c6b0b161d4ca3cf2929180e827f2 | 231 | Pfam | PF00373 | FERM central domain | 93 | 206 | 8.9E-25 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/46284|m.13208 | UnnamedSample_HQ_transcript/46284 | Coverage 0.950 too low. | 818f7b583c7c9d477be894d022afd1a4 | 687 | Pfam | PF02137 | Adenosine-deaminase (editase) domain | 374 | 687 | 1.5E-75 | T | 22-09-2020 | IPR002466 | Adenosine deaminase/editase |
| UnnamedSample_HQ_transcript/23211|m.7740 | UnnamedSample_HQ_transcript/23211 | Coverage 0.878 too low. | 8bac93b30d6b9ce4c9aab5c4e7b55e2e | 682 | Pfam | PF13927 | Immunoglobulin domain | 270 | 334 | 1.9E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/23211|m.7740 | UnnamedSample_HQ_transcript/23211 | Coverage 0.878 too low. | 8bac93b30d6b9ce4c9aab5c4e7b55e2e | 682 | Pfam | PF13927 | Immunoglobulin domain | 65 | 135 | 2.2E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/23211|m.7740 | UnnamedSample_HQ_transcript/23211 | Coverage 0.878 too low. | 8bac93b30d6b9ce4c9aab5c4e7b55e2e | 682 | Pfam | PF07679 | Immunoglobulin I-set domain | 2 | 57 | 4.7E-8 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/23211|m.7740 | UnnamedSample_HQ_transcript/23211 | Coverage 0.878 too low. | 8bac93b30d6b9ce4c9aab5c4e7b55e2e | 682 | Pfam | PF07679 | Immunoglobulin I-set domain | 158 | 251 | 2.7E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/23211|m.7740 | UnnamedSample_HQ_transcript/23211 | Coverage 0.878 too low. | 8bac93b30d6b9ce4c9aab5c4e7b55e2e | 682 | Pfam | PF00041 | Fibronectin type III domain | 353 | 436 | 5.9E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/23211|m.7740 | UnnamedSample_HQ_transcript/23211 | Coverage 0.878 too low. | 8bac93b30d6b9ce4c9aab5c4e7b55e2e | 682 | Pfam | PF00041 | Fibronectin type III domain | 470 | 554 | 7.4E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/78101|m.19387 | UnnamedSample_HQ_transcript/78101 | Coverage 0.973 too low. | 32816b82ad1175948b3ad9164229f9b7 | 334 | Pfam | PF00083 | Sugar (and other) transporter | 4 | 328 | 3.2E-38 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/2738|m.1333 | UnnamedSample_HQ_transcript/2738 | Coverage 0.061 too low. | bfe3bf2239e05a4362e37ecaea700380 | 988 | Pfam | PF00501 | AMP-binding enzyme | 399 | 848 | 2.5E-33 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/2738|m.1333 | UnnamedSample_HQ_transcript/2738 | Coverage 0.061 too low. | bfe3bf2239e05a4362e37ecaea700380 | 988 | Pfam | PF06464 | DMAP1-binding Domain | 9 | 137 | 5.2E-24 | T | 22-09-2020 | IPR010506 | DMAP1-binding domain |
| UnnamedSample_HQ_transcript/16242|m.5779 | UnnamedSample_HQ_transcript/16242 | Coverage 0.957 too low. | 67658d7f337d2575bff8a0ea7b05c3ef | 866 | Pfam | PF13895 | Immunoglobulin domain | 357 | 431 | 2.3E-7 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/16242|m.5779 | UnnamedSample_HQ_transcript/16242 | Coverage 0.957 too low. | 67658d7f337d2575bff8a0ea7b05c3ef | 866 | Pfam | PF13927 | Immunoglobulin domain | 155 | 231 | 2.5E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/16242|m.5779 | UnnamedSample_HQ_transcript/16242 | Coverage 0.957 too low. | 67658d7f337d2575bff8a0ea7b05c3ef | 866 | Pfam | PF13927 | Immunoglobulin domain | 642 | 711 | 3.8E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/16242|m.5779 | UnnamedSample_HQ_transcript/16242 | Coverage 0.957 too low. | 67658d7f337d2575bff8a0ea7b05c3ef | 866 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 56 | 135 | 2.2E-7 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/48881|m.13774 | UnnamedSample_HQ_transcript/48881 | Coverage 0.880 too low. | 8ec4c8452881036ade5df1fdc83f0b51 | 390 | Pfam | PF00781 | Diacylglycerol kinase catalytic domain | 11 | 91 | 2.3E-13 | T | 22-09-2020 | IPR001206 | Diacylglycerol kinase, catalytic domain |
| UnnamedSample_HQ_transcript/33806|m.10411 | UnnamedSample_HQ_transcript/33806 | Coverage 0.721 too low. | 8ec4c8452881036ade5df1fdc83f0b51 | 390 | Pfam | PF00781 | Diacylglycerol kinase catalytic domain | 11 | 91 | 2.3E-13 | T | 22-09-2020 | IPR001206 | Diacylglycerol kinase, catalytic domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
